Lifco Ab header image

Lifco Ab

LIFCO B

Equity

ISIN SE0015949201 / Valor 111355378

NASDAQ Nordic Exchange Stockholm, Equities (2026-06-09)
SEK 304.60+0.40%

Lifco Ab
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Lifco Ab is a company that provides a secure environment for small and medium-sized businesses. The company's main business concept is to acquire and enhance market-leading niche businesses that have the potential for sustainable earnings growth and strong cash flows. Lifco operates with a long-term perspective on its holdings, prioritizing profitability and maintaining a decentralized organizational structure. The company has three main business areas: Dental, Demolition & Tools, and Systems Solutions, with a presence in 31 countries through its 233 operating companies. In 2023, Lifco reported an EBITA margin of 23.2% on net sales of SEK 24.4 billion.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-23.9%1Y
32.7%3Y
61.6%5Y

Performance

27.1%1Y
26.0%3Y
30.5%5Y

Volatility

Market cap

13583 M

Market cap (USD)

Daily traded volume (Shares)

468,966

Daily traded volume (Shares)

1 day high/low

323.6 / 319.8

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Edgewise Therapeutics Inc
Edgewise Therapeutics Inc Edgewise Therapeutics Inc Valor: 110444153
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 34.06
Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.77%USD 26.97
Agenus Inc
Agenus Inc Agenus Inc Valor: 134326284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.96%USD 3.11
BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.46%USD 67.68
Harmony Biosciences Holdings Inc
Harmony Biosciences Holdings Inc Harmony Biosciences Holdings Inc Valor: 56295735
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.28%USD 34.10
Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited Dr. Lal PathLabs Limited Valor: 30691066
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.93%INR 1,575.35
PTC Therapeutics Inc
PTC Therapeutics Inc PTC Therapeutics Inc Valor: 2515234
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.97%USD 73.68
Encompass Health Corporation
Encompass Health Corporation Encompass Health Corporation Valor: 39085960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.05%USD 104.19
AnaptysBio, Inc.
AnaptysBio, Inc. AnaptysBio, Inc. Valor: 29675116
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.53%USD 51.63
CG Oncology Inc
CG Oncology Inc CG Oncology Inc Valor: 131996952
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.17%USD 56.67